This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with sarcoidosis-associated interstitial lung disease and pulmonary hypertension.
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All